Trastuzumab Unknown Status Phase 2 Trials for Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004163Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer